Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Andrew Last Insider Profile
4 Followers
Andrew Last, EVP & COO at Affymetrix, holds 5.04K shares in Bio-Rad Laboratories (Ticker: BIO), holds 90.17K shares in OncoCyte (Ticker: OCX), holds 4.00K shares in Precigen (Ticker: PGEN).
Profitable Transactions
0 out of 4 Profitable Transactions
Average Return
-50.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Andrew Last holds in companies
Most Profitable Insider Trade
The most profitable trade made by Andrew Last
Andrew Last's Trading History
Affymetrix
Apr 01, 2016
―
Uninformative Sell
―
$2.91M
OncoCyte
Jun 27, 2023
Director
Uninformative Buy
―
$233.54K
Precigen
Nov 15, 2017
COO
Informative Buy
24.20K
$5.24K
Bio-Rad Laboratories
Sep 06, 2023
EVP & COO
Uninformative Buy
―
$1.47M
List of latest transactions for each holding click on a transaction to see Andrew Last's performance on stock
You May Also Like
Andrew Last insider profile FAQ
What is the percentage of profitable transactions made by Andrew Last?
The percentage of profitable transactions made by Andrew Last is 0%.
What is the average return per transaction made by Andrew Last?
The average return per transaction made by Andrew Last is -50.90%.
What stocks does Andrew Last hold?
Andrew Last holds: AFFX, OCX, PGEN, BIO stocks.
What was Andrew Last’s latest transaction?
Andrew Last latest transaction was an Uninformative Buy of ―.
What was Andrew Last's most profitable transaction?
Andrew Last’s most profitable transaction was an Informative Buy of PGEN stock on November 15, 2017. The return on the trade was -18.40%.
What is Andrew Last's role in Affymetrix?
Andrew Last's role in Affymetrix is EVP & COO.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.